1
|
Affiliation(s)
- Moran Haim Zada
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Zehava Gallimidi
- Department of Medical Imaging, Rambam Healthcare Campus, Haifa 3199, Israel
| | | | - Abraham Nyska
- Sackler School of Medicine, Tel Aviv University and Consultant in Toxicologic Pathology, Timrat 36576, Israel
| | - Abraham J. Domb
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| |
Collapse
|
2
|
Haim Zada M, Kumar A, Elmalak O, Markovitz E, Icekson R, Domb AJ. In vitro and in vivo degradation behavior and the long-term performance of biodegradable PLCL balloon implants. Int J Pharm 2020; 574:118870. [DOI: 10.1016/j.ijpharm.2019.118870] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Revised: 11/10/2019] [Accepted: 11/11/2019] [Indexed: 02/06/2023]
|
3
|
Haim Zada M, Kumar A, Elmalak O, Mechrez G, Domb AJ. Effect of Ethylene Oxide and Gamma (γ-) Sterilization on the Properties of a PLCL Polymer Material in Balloon Implants. ACS Omega 2019; 4:21319-21326. [PMID: 31867526 PMCID: PMC6921626 DOI: 10.1021/acsomega.9b02889] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Accepted: 11/19/2019] [Indexed: 06/10/2023]
Abstract
Poly-l-lactide-co-ε-caprolactone (PLCL) is a unique polymer containing both polylactic acid and poly-ε-caprolactone (PCL) chain units, and thus it has better flexible and biodegradable properties. Based on these unique properties of PLCL, we have developed balloons that are now widely used in treating major medical problems [Biomaterials 2016, 105, 109-116]. One of the most important considerations needed for balloons is to ensure that the material properties remain similar after undergoing ethylene oxide (EtO) or gamma (γ-) sterilization treatments. From the biotechnological point of view, we focused on analyzing the vital molecular properties of the PLCL material after sterilization, such as changes in crystallinity, molecular weight distributions (M w, M n, and polydispersity index), and inherent viscosity (η). Analysis of the data reveals that EtO sterilization does not engender any change in crystallinity, melting temperature (T m), molecular weights, and η of the polymer. On the contrary, γ-radiations induce chain scission and consequential decrease of ∼33 and ∼15% in molecular weights and η values, respectively. Based on our observations, we recommend EtO sterilization instead of γ-radiation for PLCL. This ensures prolonged stability of the polymer against degradation in a biological environment, long-shelf life, and absolute assurance that balloon failures do not occur after implantation.
Collapse
Affiliation(s)
- Moran Haim Zada
- Institute
of Drug Research, Alex Grass Center for Drug Design and Novel Therapeutics,
School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Awanish Kumar
- Institute
of Drug Research, Alex Grass Center for Drug Design and Novel Therapeutics,
School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Omar Elmalak
- Institute
of Drug Research, Alex Grass Center for Drug Design and Novel Therapeutics,
School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Guy Mechrez
- Department
of Food Quality and Safety, Institute for Postharvest and Food Sciences,
Volcani Center, ARO, 68 HaMaccabim Road, Rishon
LeZion 7505101, Israel
| | - Abraham J. Domb
- Institute
of Drug Research, Alex Grass Center for Drug Design and Novel Therapeutics,
School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| |
Collapse
|
4
|
Abstract
Introducing temporary markers for imaging studies is an idea, which in the proper clinical settings can be advantageous for patient compliance and in selected cases where a permanent marker is nondesirable. Hence, we developed injectable marker formulation using a biodegradable "pasty polymer" of poly(ricinoleic acid-co-sebacic acid) (PSA:RA) containing iodixanol and iron oxide as contrast agents that can serve as a visual marker for the region suspected to have tumor growth. The goal of this work is to noninvasively evaluate the visibility, shape, and degradation of the injectable PSA:RA formulation using magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound (US). Prescreening of the marker formulation was performed under MRI and CT scanning using agar gel phantom models with poly(l-lactide-co-ε-caprolactone) (PCL:LA) solid inserts (clips) that contained varying combinations of the contrast agents. The contrast agent combination with the PCL:LA clip that had the best visibility in both MRI and CT was selected and additionally tested as in PSA:RA formulation. Further, we evaluated the PSA:RA marker placement in bovine liver and poultry muscles. The PSA:RA formulation is predictable with good MRI, CT, and US visibility and shows no in vivo systemic toxicity symptoms when implanted subcutaneously in mice. Further, the advantage of PSA:RA formulation is its undefined shape and ease of injecting through a small gauge needle, making it possible to reach into the regions of the body.
Collapse
Affiliation(s)
- Moran Haim Zada
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - S Nahum Goldberg
- Department of Radiology, Hadassah Medical Center, Jerusalem 91999, Israel
| | | | - Abraham J Domb
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Eliel Ben-David
- Department of Radiology, Shaare Zedek Medical Center, Jerusalem 91031, Israel
| |
Collapse
|
5
|
Zada MH, Kubek M, Khan W, Kumar A, Domb A. Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH). J Control Release 2019; 295:278-289. [PMID: 30610951 DOI: 10.1016/j.jconrel.2018.12.050] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2018] [Revised: 12/30/2018] [Accepted: 12/31/2018] [Indexed: 12/17/2022]
Abstract
Nose-to-brain delivery of drugs is affected by nanoparticles (NPs) deposited on the olfactory surface and absorbed directly into the brain. Thyrotropin releasing hormone (TRH), a water soluble drug used for treating suicidal patients, was incorporated into a fast degrading poly(sebacic anhydride) (PSA) NPs. NPs were prepared by a solvent-antisolvent process under strict anhydrous environment to obtain high TRH loading and to avoid premature PSA degradation and TRH release. PSA and TRH were dissolved in a mixture of dichloromethane and ethanol and added dropwise to a dispersion of mannitol particles in heptane as an antisolvent. Mannitol powder was included in the antisolvent, so that formed NPs adhered to the mannitol microparticles for easy isolation and immediate dispersion in water prior to use. The size, surface charge, and morphology of the TRH-PSA NPs were determined using dynamic light scattering (DLS), zeta-potential, and Scanning Electron Microscopy (SEM), respectively. The NPs prepared were uniform and spherical of ~250 nm. Further, the in vitro release profile of TRH from NPs lasted for 12 h with most TRH released within the first hour in water. Concentration dependent cell toxicity studies revealed low toxicity level at low concentrations of the NPs. Surface adsorption of the NPs was also uniform on the cell surface as examined through the odyssey near infrared fluorescence (NIR) images using Indocyanine green (ICG). The NPs are designed to enable direct delivery to the olfactory epithelium using a refillable nasal atomizer that deposits mist onto the olfactory neuro-epithelium.
Collapse
Affiliation(s)
- Moran Haim Zada
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Michael Kubek
- Anatomy & Cell Biology, Indiana University, HITS 0030L, ANAT, Indianapolis, IN, United States
| | - Wahid Khan
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Awanish Kumar
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Abraham Domb
- Institute of Drug Research, School of Pharmacy-Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
| |
Collapse
|
6
|
Affiliation(s)
- Konda Reddy Kunduru
- Department of Medicinal Chemistry
and Natural Products, Institute for Drug Research, School of Pharmacy,
Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Arijit Basu
- Department of Medicinal Chemistry
and Natural Products, Institute for Drug Research, School of Pharmacy,
Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Moran Haim Zada
- Department of Medicinal Chemistry
and Natural Products, Institute for Drug Research, School of Pharmacy,
Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Abraham J. Domb
- Department of Medicinal Chemistry
and Natural Products, Institute for Drug Research, School of Pharmacy,
Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| |
Collapse
|
7
|
Ramot Y, Touitou D, Levin G, Ickowicz DE, Zada MH, Abbas R, Yankelson L, Domb AJ, Nyska A. Interspecies Differences in Reaction to a Biodegradable Subcutaneous Tissue Filler. Toxicol Pathol 2014; 43:267-71. [DOI: 10.1177/0192623314534995] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Soft tissue filler products have become very popular in recent years, with ever-increasing medical and aesthetic indications. While generally considered safe, the number of reported complications with tissue fillers is growing. Nevertheless, there is no specific animal model that is considered as the gold standard for assessing safety or efficacy of tissue fillers, and there are very little data on interspecies differences in reaction to these products. Here, we report on interspecies differences in reaction to a subcutaneous injectable co-polyester, composed of castor oil and citric acid. Comparison of the histopathological local tissue changes following 1-month postimplantation, indicated that in rats the reaction consisted of cavities, surrounded by relatively thin fibrotic enveloping capsule. In contrast, an unexpected severe inflammatory granulomatous reaction was noticed in Sinclair minipigs. To our knowledge, this is the first report on significant interspecies differences in sensitivity to tissue fillers. It emphasizes the importance of using the appropriate animal model for performing preclinical biocompatibility assays for biodegradable polymers, tissue fillers, and implanted medical devices in general. It also makes the Sinclair minipig subject for scrutiny as an animal model in future biocompatibility studies.
Collapse
Affiliation(s)
- Yuval Ramot
- Hadassah–Hebrew University Medical Center, Jerusalem, Israel
| | | | | | - Diana E. Ickowicz
- Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, Jerusalem, Israel
| | - Moran Haim Zada
- Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, Jerusalem, Israel
| | | | | | - Abraham J. Domb
- Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, Jerusalem, Israel
| | - Abraham Nyska
- Tel Aviv University and consultant in toxicologic pathology, Timrat, Tel Aviv, Israel
| |
Collapse
|